Skip to main content Back to Top
Advertisement

6/1/2022

5% Dextrose Injection Large Volume Bags

Products Affected - Description

    • 5% Dextrose injection, Baxter, 1000 mL bag, 1 count, NDC 00338-0017-04
    • 5% Dextrose injection, Baxter, 250 mL bag, 36 count, NDC 00338-0017-02
    • 5% Dextrose injection, Baxter, 500 mL bag, 24 count, NDC 00338-0017-03
    • 5% Dextrose injection, Pfizer, 250 mL ADD-Vantage flexible container, 24 count, NDC 00409-7100-02

Reason for the Shortage

    • Baxter has 5% dextrose injection on shortage due to increased demand.
    • ICU Medical had 5% dextrose injection on shortage due to increased demand.
    • Pfizer has 5% dextrose injection on shortage due to manufacturing delay.

Available Products

    • 5% Dextrose injection, ICU Medical, 1000 mL bag, 1 count, NDC 00409-7922-09
    • 5% Dextrose injection, ICU Medical, 250 mL (2 port) bag, 24 count, NDC 00409-7922-02
    • 5% Dextrose injection, ICU Medical, 500 mL (2 port) bag, 18 count, NDC 00409-7922-55
    • 5% Dextrose injection, ICU Medical, 500 mL bag, 24 count, NDC 00409-7922-03

Estimated Resupply Dates

    • Baxter has 5% dextrose 250 mL, 500 mL, and 1,000 mL Viaflex bags on allocation.
    • Pfizer has 5% dextrose 250 mL ADD-Vantage bags on backorder and the company estimates a release date of June 2022.

Updated

Updated June 1, 2022 by Anthony Trovato, PharmD, BCPS. Created February 4, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.